Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
U.S. Shifts Stance on Drug Pricing in Pacific Trade Pact Talks, Document Reveals

Facing resistance from Pacific trading partners, the Obama administration is no longer demanding protection for pharmaceutical prices under the 12-nation Trans-Pacific Partnership, according to a newly leaked section of the proposed trade accord.

Published
12 June 2015
From
New York Times
The Medicines Patent Pool and Gilead Sciences Expand Licence to Allow Generic Manufacture of Medicines in South Africa

The Medicines Patent Pool (MPP) announced an expansion of its current licensing agreement with Gilead Sciences for generic manufacture of tenofovir alafenamide (TAF), tenofovir disoproxil fumarate (TDF) and other Gilead medicines. The amendment enhances MPP’s current licence by allowing South African manufacturers to join Indian and Chinese companies in developing generics for low- and middle-income countries.

Published
12 June 2015
From
Medicines Patent Pool
When to START has never been clearer

Posirtive Lite editor Bob Leahy in conversation with CATIE’s Sean Hosein about START, the important and ground-breaking study that recently provided definitive evidence of the health benefits of starting HIV treatment sooner rather than later.

Published
10 June 2015
From
Positive Lite
Fireworks at AIDS conference

“We say it is unacceptable that internal party politics means that an underperforming and uncommitted MEC for Health like Benny Malakoane is untouchable. Malakoane must be replaced,” said Mavasa. The audience cheered. Malakoane stared straight ahead, chewing gum.

Published
10 June 2015
From
Ground Up
Medical cannabis company donates $1 million to explore plant’s healing potential

Medical marijuana producer National Green Biomed Ltd. has committed $1 million to the University of British Columbia to allow researchers to study the therapeutic effects of cannabis. The company has made an application and is awaiting approval from Health Canada to produce and sell medical marijuana. The contribution will support research by assistant professor of medicine M-J Milloy, who is studying marijuana’s potential to treat HIV, and alleviate pain and nausea caused by acute illness and medications used to combat HIV and AIDS.

Published
09 June 2015
From
University of British Columbia press release
Pharma Execs Don't Know Why Anyone Is Upset by a $94,500 Miracle Cure

The company selling a costly breakthrough to millions of hepatitis C sufferers thinks price is the wrong thing to talk about.

Published
09 June 2015
From
Bloomberg
Most gay men with HIV in central European capitals are undiagnosed, survey has found

A survey of gay men in the European cities of Barcelona, Bratislava, Bucharest, Ljubljana, Prague and Verona has found that in all cities but Barcelona the majority

Published
09 June 2015
By
Gus Cairns
Luxembourg EU Presidency to champion access to breakthrough therapies

At the conference, hosted by the Brussels based European Alliance for Personalised Medicine (EAPM), the minister told attendees that: "Personalised medicine will be a thematic focus of the Luxembourgish presidency,” which will “highlight opportunities to accelerate progress”.

Published
08 June 2015
From
European Alliance for Personalised Medicine press release
UNITAID brings innovation to the global response to HIV/AIDS, TB and Malaria

At a meeting in Rio de Janeiro, the Executive Board announced it would as a first step focus investments in three areas: improving antiretroviral therapy for adults in low and middle-income countries; enabling the expanded use, or "scale-up", of first pre-exposure prophylaxis (PrEP) as a means of preventing HIV transmission; and the development of better tools to diagnose hepatitis C virus (HCV), in particular for people who are co-infected with HIV/HCV.

Published
08 June 2015
From
UNITAID
Early HIV Treatment Is Essential, But So Is Testing And Linkage To Care

Last week’s announcement of the Strategic Timing of AntiRetroviral Treatment (START) trial results confirms what many experts have long believed — early treatment for HIV reduces illness and death. While START further establishes the vital role of early antiretroviral therapy (ART), many questions remain on how to actually bring the life-saving benefits of treatment to individual patients.

Published
05 June 2015
From
Health Affairs (blog)

Filter by country